Bone graft substitutes: Towards a more perfect union

Orthopedics

Volumn 26, Issue 9, 2003, Pages 925-926

  Bauer, Thomas W ^a   Togawa, Daisuke ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; HYDROXYAPATITE; POLY(METHYL METHACRYLATE);

ARTICLE; BONE CONDUCTION; BONE GRAFT; BONE MATRIX; BONE MINERALIZATION; BONE TRANSPLANTATION; CHEMICAL COMPOSITION; COMPRESSIVE STRENGTH; HUMAN; INTERMETHOD COMPARISON; OSSIFICATION; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; BONE CEMENTS; BONE MATRIX; BONE SUBSTITUTES; BONE TRANSPLANTATION; CALCIUM PHOSPHATES; CALCIUM SULFATE; CERAMICS; DURAPATITE; HUMANS; HYDROXYAPATITES; INJECTIONS; OSTEOGENESIS; POLYMETHYL METHACRYLATE;

EID: 0141521497     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop. 2000; 371:10-27.
2. Bucholz RW, Carlton A, Holmes R. Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Clin Orthop. 1989; 240:53-62.
3. Bucholz RW. Nonallograft osteoconductive bone graft substitutes. Clin Orthop. 2002; 395:44-52.
4. Tay BK, Le AX, Heilman M, Lotz J, Bradford DS. Use of a collagen-hydroxyapatite matrix in spinal fusion. A rabbit model. Spine. 1998; 23:2276-2281.
5. Gunzburg R, Szpalski M. Use of a novel beta-tricalcium phosphate-based bone void filler as a graft extender in spinal fusion surgeries. Orthopedics. 2002; 25(Suppl):S591-S595.
6. Chapman M, Bucholz R, Cornell C. Treatment of acute fractures with a collagen-calcium phosphate graft material. A randomized clinical trial. J Bone Joint Surg Am. 1997; 79:495-502.
7. Turner TM, Urban RM, Gitelis S, Kuo KN, Andersson GB. Radiographic and histologic assessment of calcium sulfate in experimental animal models and clinical use as a resorbable bone-graft substitute, a bone-graft expander, and a method for local antibiotic delivery. One institution's experience. J Bone Joint Surg Am. 2001; 83(Suppl):S8-S18.
8. Erbe EM, Marx JG, Clineff TD, Bellincampi LD. Potential of an ultraporous beta-tricalcium phosphate synthetic cancellous bone void filler and bone marrow aspirate composite graft. Eur Spine J. 2001; 10(Suppl):S141-S146.
9. Larsson S, Bauer TW. Use of injectable calcium phosphate cement for fracture fixation: a review. Clin Orthop. 2002; 395:23-32.
10. Pomrink GJ, DiCicco MP, Clineff TD, Erbe EM. Evaluation of the reaction kinetics of Cortoss, a thermoset cortical bone void filler. Biomaterials. 2003; 24:1023-1031.
11. Urist MR. Bone: formation by autoinduction. Science. 1965; 150:893-899.
12. Takikawa S, Bauer TW, Kambic H, Togawa D. A comparative evaluation of the osteoinductivity of two formulations of human demineralized bone matrix. J Biomed Mater Res. 2003; 65:37-42.
13. Slater M, Patava J, Kingham K, Mason RS. Involvement of platelets in stimulating osteogenic activity. J Orthop Res. 1995; 13:655-663.
14. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001; 83(Suppl):S151-S158.
15. Valentin-Opran A, Wozney J, Csimma C, Lilly L, Riedel GE. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop. 2002; 395:110-120.